Prostate cancer is the 2nd most common cause of cancer death in U.S. men. While initial treatments offer hope, many patients find that their cancer returns with often fatal outcomes. But what if the key to stopping this deadly progression lies in our genes?

Dr. Nima Sharifi, scientific director of the Desai Sethi Urology Institute, discovered a specific genetic variant that enables tumors to bypass treatments, effectively producing their own hormones to fuel cancer growth.

Tune in!